Scope of the Study
Custom Antibody Services provides highly specific, and high-quality products, which are designed just for the individuals, which enables to develop innovative solutions to advance scientific discovery. It includes competitively priced packages and purification options for antibody production. These are supported by online tools for peptide design and project tracking. The custom antibody service provide support for all types and steps of antibody production like peptide design, synthesis, and carrier protein conjugation, animal immunisation, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
The market study is being classified by Type (Antibody Development, Antigen Preparation, Immunisation & Hybridoma Production, Antibody Characterisation, Antibody Production & Purification and Antibody Fragmentation & Labelling) and major geographies with country level break-up.
Thermo Fisher Scientific Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Merck Group (Germany), Abcam plc (United Kingdom), Cell Signaling Technology, Inc. (United States), Agilent Technologies, Inc. (United States), GenScript (United States), BioLegend, Inc. (United States), Rockland Immunochemicals (United States) and ProMab Biotechnologies (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Innovagen AB (Sweden) and ProteoGenix (United States).
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Custom Antibody Service market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Custom Antibody Service market by Type, Application and Region.
On the basis of geography, the market of Custom Antibody Service has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Research Activities in life Sciences Industry
- Rising Industry Academia Collaboration
- Increasing Research Activities in the Field of mAb-based Therapeutics
- High Expenses Involved in the Production of Antibodies
- Expansion in Antibody Therapeutics Pipeline
- Increasing Quality Concerns over Catalog Antibodies
- High Competition due to the Presence of Major Player
In 2018, Abcam launched the (PBS)-only recombinant antibodies and the new anti-PD-L1 antibody clone MKP1A07310 (clone 73-10) which is developed in collaboration with Merck KGaA
Key Target AudienceCustom antibody service provider, Manufacturers, Government associations, Research organisations, Enterprise software vendors and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase